MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

FDA Makes Quality the Rule

An MD&DI January 1997 Feature Article


Part 1: FDA's final revision of the medical device GMP regulation brings U.S. manufacturing into line with international quality systems standards.

(Note: Part 2 of this article is now available on our Web site.)

On October 7, 1996, FDA published the long-awaited revision of its
medical device good
manufacturing practices (GMP)
regulation in the Federal Register.1
Manufacturers that have not remained current with the changes in the regulation
that the agency has proposed over the past six years are in for a major
surprise. And even those that have kept current with the agency's proposals up
through the working draft of July 1995 will find a few new twists.

Now renamed as a quality system regulation, FDA's new revision differs
significantly from the previous GMP regulation of 1978.2 It also
adds a number of requirements not present in the agency's proposed rule of
November 1993, and introduces a number of changes developed since publication of
the July 1995 working draft.3,4 Specifically, the new quality system
regulation contains major additional requirements in the areas of design,
management responsibility, purchasing, and servicing.

It is clear that the new regulation has been greatly influenced by the work of
the Global Harmonization Task Force.5 In slightly different wording,
the regulation now incorporates all the requirements of
ISO 9001, the fullest of
the quality systems standards compiled by the International
Organization for Standardization (ISO)
.6 For example, there are
now requirements for quality planning, for a quality manual, and for an outline
of the general quality procedure. All these new requirements were added in order
to bring the regulation into harmony with the quality systems standards
currently accepted in the member nations of the European Union (EU), and there
is certainly a benefit to their inclusion in the new regulation.

But the regulation also adds documentation requirements that would not have been
included if harmonization were not an agency goal, and these requirements must
now be met by all U.S. device manufacturers--even if they do not intend to
export to the EU. On the up side, the language of the new regulation will allow
manufacturers much more flexibility than either the November 1993 proposal or
July 1995 working draft would have allowed. In the pages that follow, this
article will review the changes that the agency has incorporated into the
sections of its newest regulation and will discuss how those changes are likely
to affect device manufacturers.





Copyright © 1997 Medical Device & Diagnostic Industry

500 characters remaining